Skip to main content
1006-2023, 1006-2028, 1005-2016
class com.aha.ucm.component.cis.TagListPageData=[,docNativeURL=null,docName=UCM_496491,docStatus=RELEASED,dOutDate=null,docSSFileName=UCM_496491_ICYMI-Hypertension-in-Pregnancy.jsp,docTitle=ICYMI: Hypertension in Pregnancy,xWebsites=professional,dDocAuthor=stacey.sims,xNextReviewDate=09/22/2016 5:42 PM,xTier1=36,xFeaturedItem=No,xElectronicRegistration=No,UserLocale=null,xSubCategory=,dpEvent=null,xComments=Labetalol Versus Nifedipine as Antihypertensive Treatment for Chronic Hypertension in Pregnancy: a Randomised Trial,NoHttpHeaders=null,UserTimeZone=null,xRegionDefinition=GENERIC_RD_COL_1,xVideoRenditions=,xSnippetItem=,xNotes=,UserDateFormat=null,encodeDocUrl=null,isDocProfileDone=null,xKeywords=Hypertension, Labetalol, Nifedipine, Antihypertensive Treatment, Chronic Hypertension in Pregnancy,xTier2=,refreshSubMonikers=null,xEditorStepReassignedUsers=null,xLinkTextToDisplay=,dDocAccount=WCM/SOP/SPUB,xEndDateTime=null,xClbraAliasList=null,ClientEncoding=null,xCpdIsLocked=0,xUsageRightsDate=null,xModifyDate=09/21/2017 9:40 PM,xTier3=,xEventDate=null,dSubscriptionType=null,xCopyright=No,xPackagedConversions=,dSubscriptionAlias=null,xStorageRule=,dpName=null,xDepartment=Science Operations,dStatus=RELEASED,dPublishType=,xCopyrightDetails=,xSubType=64,isDocProfileUsed=null,xWebsiteObjectType=Data File,xWebFlag=,xSeeAlsoLinks=,xClbraUserList=null,xPartitionId=,xCpdIsTemplateEnabled=0,xLinkWebAddress=,xDontShowInListsForWebsites=,xStartDateTime=null,dInDate=09/21/2017 9:33 PM,xWebsiteSection=professional:1463,dDocName=UCM_496491,dpAction=null,dRevLabel=1,dSecurityGroup=AHAMAH-Public,xCategory=,refreshMonikers=null,xDamConversionType=,dDocFormats=null,xAssociatedImage=,dDocType=SingleColumn,xBusinessOwner=Business Owner,xUploadDate=null,xDiscussionCount=0,xMainFlowEntryCriteria=True,xItemInformation=,xUsageRights=,xDiscussionType=N/A,xRecipeTaxonomy=,dSubscriptionID=null,dOriginalName=UCM_496491.xml,xProfileTrigger=SingleColumn,dLocation=,dRevisionID=1,dPublishState=,dReleaseState=Y,xTrashDeleter=null,dMessage=,dWebExtension=xml,dExtension=xml,dProcessingState=Y,xTrashDeleteName=null,dIsCheckedOut=0,xForceFolderSecurity=null,dRevClassID=496491,dIsPrimary=1,dFileSize=7216,dIndexerState=,dFlag1=,xviaAddNewContentService=,dIsWebFormat=0,xCollectionID=null,dRevRank=0,xReadOnly=null,dCheckoutUser=,dFormat=Application/xml,dWorkflowState=,dDocID=1783630,dRendition2=,dRendition1=,xInhibitUpdate=null,dReleaseDate=09/21/2017 9:40 PM,xTrashDeleteLoc=null,dCreateDate=09/21/2017 9:40 PM,xHidden=null,labelTier1=ScienceNews,labelTier2=,labelTier3=,labelTier4=,mobileNavURL=DEFAULT2_VALUE_FROM_getDataForAdvanceSearch,xContactPhoneNumber=,xContactEmailAddress=,xContactName=,xATGRolesDisciplines=,xPublishDate=09/21/2017 5:00 AM,xRobotParameter=,xCommunities=1006-2023, 1006-2028, 1005-2016,xMembershipLevel=,rsCalories=null,rsSodium=null,rsRecipeTaxonomy=null,rsServings=null,rsTotalTime=null,rsTotalFat=null,rsTotalCarbs=null,rsFeaturedImage=null,xDisplayComments=
Hypertension

ICYMI: Featured Article on Hypertension in Pregnancy

Labetalol Versus Nifedipine as Antihypertensive Treatment for Chronic Hypertension in Pregnancy: a Randomised Trial

Author Perspective

Labetalol and nifedipine control mean systolic and diastolic BP to target in pregnant women with chronic hypertension. Good recruitment was demonstrated, and mechanistic treatment effects observed. This study provides support for a larger definitive trial scrutinizing the benefits and side effects of firstline antihypertensive treatment in pregnancy complicated by chronic hypertension.

HTN Clinical Implications footer